Key facts
- This page summarizes Valerie Barber Palmieri's Form 4 filing for Aspira Women's Health Inc. (AWHL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 May 2022, 09:22.
Valerie Barber Palmieri - 16 May 2022 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)
- Reporting relationship
- Executive Chair, Director
- Issuer ticker
- AWHL
- Reported as of
- 16 May 2022
- Net transaction value
- +$24,918
- Reporting owner signature
- /s/ Valerie Palmieri
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Valerie Barber Palmieri filed Form 4 for Aspira Women's Health Inc. (AWHL) on 18 May 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$24,918.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AWH
transaction
Common Stock
Purchase
- Transaction value
- $24,918
- Shares
- +43,994
- Change %
- +20%
- Price
- $0.5664
- Shares after
- 267,088
- Date
- 16 May 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The purchase price reported in column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.4928 to $0.6000 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.